Multi-drug-resistant Klebsiella pneumoniae in hospital acquired infections: concomitant analysis of antimicrobial resistant strains.
Hospital acquired infections caused by K. pneumoniae are difficult to eradicate since K. pneumoniae carries resistance genes for many antimicrobials, including carbapenems. The study aimed to determine the prevalence of hospital acquired infections caused by multiple drug resistant K. pneumoniae and identify carbapenem and fluoroquinolone resistance by phenotypic and genotypic methods among hospitalized patients. Two hundred and fifty samples from patients with hospital acquired infections were included. Identification and susceptibility testing for K. pneumoniae isolates were performed by standard methods. The detection of carbapenemase resistance (blaKPC , blaVIM-1 and blaOXA-48 ) and plasmid mediated quinolone resistance (PMQR; qnrA, qnrB and qnrS) genes was performed using PCR assay. Out of 250 samples, 42 (16.8 %) were multiple drug resistant K. pneumoniae, the frequency of K. Pneumoniae isolation was higher in urine samples, in the age group (< 10 years), in ICU and in patients with longer hospital stay. Twenty-four (57%) of the isolates were resistant to Meropenem, 13(31%) were resistant to Imipenem and 35(83.3%) were resistant to Ciprofloxacin. blaOXA-48 gene was detected in 9 (21.4%) of isolates and blaVIM-1 gene was detected in 6 (14.3%) of isolates. However, no isolate harbored blaKPC gene. PMQR genes were detected in 100% of ciprofloxacin resistant isolates and qnrS was the dominant. Multidrug-resistant K. pneumoniae isolates harboring blaOXA-48, blaVIM-1 and PMQR genes are emerging in hospitals particularly with long hospital stays.